Responses
Regular and young investigator award abstracts
Combination immunotherapies
449 Neoadjuvant cyclic dinucleotides combined with interleukin-2 and anti-PD-1 antibody limit lung metastasis of orthotopic breast tumors through prolonged NK cell activation
Compose a Response to This Article
Other responses
No responses have been published for this article.
